drugset / Trial / NCT04890548
Study to Evaluate the Effects of AZD3427 in Patients With Heart Failure
NaSingle-groupOpen-labelTreatment
Summary
The primary purpose of this mechanistic study is to evaluate the vasodilatory effects of AZD3427 in adult patients with heart failure and will be performed at approximately 2 study sites in the United Kingdom.
Timeline
- Start
- 2021-11-23
- Primary completion
- 2022-08-02
- Completion
- 2022-08-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD3427 | Unknown | — | Other |